Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose vs Standard Dose IMVAMUNE for Smallpox
NCT00879762Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2009
- Primary completion
- Mar 2011
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of JYNNEOS in smallpox, sponsored by National Institute of Allergy and Infectious Diseases. Started May 2009; status: completed.
02
Drugs
JYNNEOS
03
Conditions
smallpox
Beyond the preview
Go deeper on NCT00879762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879762.